{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:10:44Z","timestamp":1793970644513,"version":"4.8.0"},"reference-count":146,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes on Health (NIH)","award":["5 R01 AG071228-02"],"award-info":[{"award-number":["5 R01 AG071228-02"]}]},{"name":"National Institutes on Health (NIH)","award":["R01AG070153"],"award-info":[{"award-number":["R01AG070153"]}]},{"name":"National Institutes on Health (NIH)","award":["R01AG061566"],"award-info":[{"award-number":["R01AG061566"]}]},{"name":"National Institutes on Health (NIH)","award":["CA2018010"],"award-info":[{"award-number":["CA2018010"]}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["5 R01 AG071228-02"],"award-info":[{"award-number":["5 R01 AG071228-02"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["R01AG070153"],"award-info":[{"award-number":["R01AG070153"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["R01AG061566"],"award-info":[{"award-number":["R01AG061566"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["CA2018010"],"award-info":[{"award-number":["CA2018010"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Numerous investigations have demonstrated significant and long-lasting neurological manifestations of COVID-19. It has been suggested that as many as four out of five patients who sustained COVID-19 will show one or several neurological symptoms that can last months after the infection has run its course. Neurological symptoms are most common in people who are less than 60 years of age, while encephalopathy is more common in those over 60. Biological mechanisms for these neurological symptoms need to be investigated and may include both direct and indirect effects of the virus on the brain and spinal cord. Individuals with Alzheimer\u2019s disease (AD) and related dementia, as well as persons with Down syndrome (DS), are especially vulnerable to COVID-19, but the biological reasons for this are not clear. Investigating the neurological consequences of COVID-19 is an urgent emerging medical need, since close to 700 million people worldwide have now had COVID-19 at least once. It is likely that there will be a new burden on healthcare and the economy dealing with the long-term neurological consequences of severe SARS-CoV-2 infections and long COVID, even in younger generations. Interestingly, neurological symptoms after an acute infection are strikingly similar to the symptoms observed after a mild traumatic brain injury (mTBI) or concussion, including dizziness, balance issues, anosmia, and headaches. The possible convergence of biological pathways involved in both will be discussed. The current review is focused on the most commonly described neurological symptoms, as well as the possible molecular mechanisms involved.<\/jats:p>","DOI":"10.3390\/jcm12093190","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T10:51:52Z","timestamp":1682679112000},"page":"3190","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms"],"prefix":"10.3390","volume":"12","author":[{"given":"Ann-Charlotte","family":"Granholm","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Denver, CO 80045-0511, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e18606","DOI":"10.2196\/18606","article-title":"Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England","volume":"6","author":"Zambon","year":"2020","journal-title":"JMIR Public Health Surveill."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.34172\/aim.2020.09","article-title":"Epidemiology and Clinical Characteristics of COVID-19","volume":"23","author":"Huang","year":"2020","journal-title":"Arch. Iran. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacr.2020.02.008","article-title":"Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know","volume":"17","author":"Kooraki","year":"2020","journal-title":"J. Am. Coll. Radiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3201\/eid2607.200841","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","first-page":"55","article-title":"COVID-19, a worldwide public health emergency","volume":"221","author":"Santos","year":"2020","journal-title":"Rev. Clin. Esp."},{"key":"ref_7","first-page":"55","article-title":"Viral infections and their relationship to neurological disorders","volume":"221","author":"Wouk","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"Marcocci","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1476-5381.1990.tb14156.x","article-title":"Prevention by the NMDA receptor antagonist, MK801 of neuronal loss produced by tetanus toxin in the rat hippocampus","volume":"101","author":"Bagetta","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1743-422X-10-172","article-title":"Viruses and neurodegeneration","volume":"10","author":"Zhou","year":"2013","journal-title":"Virol. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.mehy.2010.02.023","article-title":"Neuroinflammation resulting from covert brain invasion by common viruses\u2014A potential role in local and global neurodegeneration","volume":"75","author":"Majde","year":"2010","journal-title":"Med. Hypotheses"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105254","DOI":"10.1016\/j.meegid.2022.105254","article-title":"Understanding on the possible routes for SARS-CoV-2 invasion via ACE2 in the host linked with multiple organs damage","volume":"99","author":"Kirtipal","year":"2022","journal-title":"Infect. Genet. Evol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","article-title":"The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ding, Q., Shults, N.V., Gychka, S.G., Harris, B.T., and Suzuki, Y.J. (2021). Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041687"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113837","DOI":"10.1016\/j.expneurol.2021.113837","article-title":"ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations","volume":"345","author":"Hernandez","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbrc.2020.09.042","article-title":"The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues","volume":"533","author":"Qiao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11481-021-10015-6","article-title":"Mitochondrial Dynamics in SARS-CoV-2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID","volume":"16","author":"Clough","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/ane.13657","article-title":"Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment","volume":"146","author":"Zhang","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/acs.jproteome.2c00184","article-title":"Protein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain","volume":"21","author":"Lindskog","year":"2022","journal-title":"J. Proteome Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e0109122","DOI":"10.1128\/spectrum.01091-22","article-title":"SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death","volume":"10","author":"Jeong","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.cell.2022.06.008","article-title":"Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation","volume":"185","author":"Lu","year":"2022","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","article-title":"Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age","volume":"11","author":"Bilinska","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbi.2020.12.031","article-title":"Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?","volume":"95","author":"Burks","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1002\/jmv.26911","article-title":"Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2","volume":"93","author":"Abbasi","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wettstein, L., Kirchhoff, F., and Munch, J. (2022). The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031351"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neucli.2021.01.003","article-title":"Sudomotor dysfunction in patients recovered from COVID-19","volume":"51","author":"Hinduja","year":"2021","journal-title":"Neurophysiol. Clin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100210","DOI":"10.1016\/j.bbih.2021.100210","article-title":"Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature","volume":"12","author":"Pizzanelli","year":"2021","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s42399-020-00715-0","article-title":"Care for Older People with Dementia During COVID-19 Pandemic","volume":"3","author":"Emmerton","year":"2021","journal-title":"SN Compr. Clin. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Yu, Y., Travaglio, M., Popovic, R., Leal, N.S., and Martins, L.M. (2021). Alzheimer\u2019s and Parkinson\u2019s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Geriatrics, 6.","DOI":"10.3390\/geriatrics6010010"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"695738","DOI":"10.3389\/fncel.2021.695738","article-title":"The Hippocampal Vulnerability to Herpes Simplex Virus Type I Infection: Relevance to Alzheimer\u2019s Disease and Memory Impairment","volume":"15","author":"Yong","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale Analysis of Independent Alzheimer\u2019s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5662\/wjm.v12.i4.200","article-title":"COVID-19 disease and autoimmune disorders: A mutual pathway","volume":"12","author":"Saeed","year":"2022","journal-title":"World J. Methodol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"664664","DOI":"10.3389\/fneur.2021.664664","article-title":"Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy","volume":"12","author":"Bhagavati","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102506","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodriguez","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3906\/sag-2004-168","article-title":"COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.sjbs.2016.02.019","article-title":"Challenges presented by MERS corona virus, and SARS corona virus to global health","volume":"23","year":"2016","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13760-020-01412-4","article-title":"Neurological manifestations of COVID-19, SARS and MERS","volume":"120","author":"Verstrepen","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100290","DOI":"10.1016\/j.ensci.2020.100290","article-title":"Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders?","volume":"21","author":"Anwar","year":"2020","journal-title":"eNeurologicalSci"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dube, M., and Talbot, P.J. (2019). Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?. Viruses, 12.","DOI":"10.3390\/v12010014"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42269-020-00478-7","article-title":"The neuropathological impact of COVID-19: A review","volume":"45","year":"2021","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/B978-0-323-91532-8.00004-5","article-title":"Neurologic complications of coronavirus and other respiratory viral infections","volume":"189","author":"Cavallieri","year":"2022","journal-title":"Handb. Clin. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"634827","DOI":"10.3389\/fneur.2021.634827","article-title":"Neurologic Manifestations of the World Health Organization\u2019s List of Pandemic and Epidemic Diseases","volume":"12","author":"McEntire","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","article-title":"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)","volume":"268","author":"Harapan","year":"2021","journal-title":"J. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13013","DOI":"10.1111\/bpa.13013","article-title":"SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19","volume":"31","author":"Maiese","year":"2021","journal-title":"Brain Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10072-021-05068-7","article-title":"Neuropathologic findings of patients with COVID-19: A systematic review","volume":"42","author":"Pajo","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/brain\/awab148","article-title":"COVID-19 neuropathology at Columbia University Irving Medical Center\/New York Presbyterian Hospital","volume":"144","author":"Thakur","year":"2021","journal-title":"Brain"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1128\/JVI.74.19.8913-8921.2000","article-title":"Neuroinvasion by human respiratory coronaviruses","volume":"74","author":"Arbour","year":"2000","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.idc.2019.07.001","article-title":"Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features","volume":"33","author":"Hui","year":"2019","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e2112","DOI":"10.1002\/rmv.2112","article-title":"Comparison of confirmed COVID-19 with SARS and MERS cases\u2014Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis","volume":"30","author":"Pormohammad","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"m641","DOI":"10.1136\/bmj.m641","article-title":"Coronavirus COVID-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","article-title":"(18)F-FDG brain PET hypometabolism in patients with long COVID","volume":"48","author":"Guedj","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41467-021-21040-7","article-title":"A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients","volume":"12","author":"Grossberg","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"20957","DOI":"10.1038\/s41598-020-78050-6","article-title":"Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories","volume":"10","author":"Mirfazeli","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/1747493020937189","article-title":"Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019","volume":"15","author":"Sweid","year":"2020","journal-title":"Int. J. Stroke"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"649922","DOI":"10.3389\/fcvm.2021.649922","article-title":"Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology","volume":"8","author":"Shahjouei","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12688\/f1000research.28393.1","article-title":"Anosmia and dysgeusia in SARS-CoV-2 infection: Incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms\u2014A systematic review and meta-analysis","volume":"10","author":"Mutiawati","year":"2021","journal-title":"F1000Research"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2022.07.006","article-title":"Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection","volume":"136","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"115094","DOI":"10.1016\/j.diagmicrobio.2020.115094","article-title":"Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review","volume":"98","author":"Guaman","year":"2020","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12974-022-02579-8","article-title":"COVID-19 and cognitive impairment: Neuroinvasive and blood\u2013brain barrier dysfunction","volume":"19","author":"Chen","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNN.0000000000000305","article-title":"Delirium as a Presenting Symptom of COVID-19","volume":"35","author":"Tyson","year":"2022","journal-title":"Cogn. Behav. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1177\/0333102420965157","article-title":"Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution","volume":"40","author":"Caronna","year":"2020","journal-title":"Cephalalgia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/17512433.2021.1902303","article-title":"Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence","volume":"14","author":"Rahman","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_68","first-page":"574","article-title":"COVID-19 Pandemic and Children: A Review","volume":"25","author":"Rathore","year":"2020","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Rando, H.M., Bennett, T.D., Byrd, J.B., Bramante, C., Callahan, T.J., Chute, C.G., Davis, H.E., Deer, R., Gagnier, J., and Koraishy, F.M. (2021). Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv.","DOI":"10.1101\/2021.03.20.21253896"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s10194-022-01450-8","article-title":"Long COVID headache","volume":"23","author":"Tana","year":"2022","journal-title":"J. Headache Pain"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"106440","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106440","article-title":"Stroke Associated with COVID-19 Vaccines","volume":"31","author":"Kakovan","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10760296211056648","DOI":"10.1177\/10760296211056648","article-title":"An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations","volume":"28","author":"Kantarcioglu","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sriwastava, S., Sharma, K., Khalid, S.H., Bhansali, S., Shrestha, A.K., Elkhooly, M., Srivastava, S., Khan, E., Jaiswal, S., and Wen, S. (2022). COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci., 12.","DOI":"10.3390\/brainsci12030407"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2911333","DOI":"10.1155\/2022\/2911333","article-title":"Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review","volume":"2022","author":"Bhandari","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000518581","article-title":"The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline","volume":"21","author":"Pyne","year":"2021","journal-title":"Neurodegener. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1021\/acschemneuro.0c00434","article-title":"Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses","volume":"11","author":"Barrantes","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"102254","DOI":"10.1016\/j.isci.2021.102254","article-title":"Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19","volume":"24","author":"Deng","year":"2021","journal-title":"iScience"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"9293553","DOI":"10.1155\/2021\/9293553","article-title":"Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It","volume":"2021","author":"Urmila","year":"2021","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"NPJ Aging Mech. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jnr.23404","article-title":"Conversion of Abeta43 to Abeta40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme","volume":"92","author":"Liu","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"173899","DOI":"10.1016\/j.ejphar.2021.173899","article-title":"Association of ACE inhibitors and Angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study","volume":"896","author":"Parit","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/NEN.0b013e31828e24ab","article-title":"Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-beta immunoreactivity after traumatic brain injury in 3xTG-AD mice","volume":"72","author":"Bennett","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40035-022-00316-y","article-title":"The COVID-19 pandemic and Alzheimer\u2019s disease: Mutual risks and mechanisms","volume":"11","author":"Chen","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s40478-021-01302-7","article-title":"APOE epsilon4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: A Finnish biobank, autopsy and clinical study","volume":"9","author":"Kurki","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ageing\/afab153","article-title":"Delirium in COVID-19: Common, distressing and linked with poor outcomes... can we do better?","volume":"50","author":"Peterson","year":"2021","journal-title":"Age Ageing"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/neu.2017.5257","article-title":"Divergent Classification Methods of Post-Concussion Syndrome after Mild Traumatic Brain Injury: Prevalence Rates, Risk Factors, and Functional Outcome","volume":"35","author":"Voormolen","year":"2018","journal-title":"J. Neurotrauma"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/bjsports-2022-106436","article-title":"Higher rates of concussion following COVID-19 infection in high school athletes","volume":"57","author":"Bullock","year":"2023","journal-title":"Br. J. Sport. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"688254","DOI":"10.3389\/fimmu.2021.688254","article-title":"Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1","volume":"12","author":"Bodnar","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10787-021-00806-x","article-title":"Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection","volume":"29","author":"Welcome","year":"2021","journal-title":"Inflammopharmacology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.2020.7332","article-title":"Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients","volume":"38","author":"DeKosky","year":"2021","journal-title":"J. Neurotrauma"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-019-0213-5","article-title":"Dissemination of brain inflammation in traumatic brain injury","volume":"16","author":"Shi","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"646924","DOI":"10.3389\/fnagi.2021.646924","article-title":"Cellular Senescence in Brain Aging","volume":"13","author":"Sikora","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","article-title":"Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States","volume":"27","author":"Mattson","year":"2018","journal-title":"Cell Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1007\/s12035-021-02399-6","article-title":"A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development","volume":"58","author":"Karnik","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"100127","DOI":"10.1016\/j.bbih.2020.100127","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives","volume":"7","author":"Vargas","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Mavrikaki, M., Lee, J.D., Solomon, I.H., and Slack, F.J. (2021). Severe COVID-19 induces molecular signatures of aging in the human brain. medRxiv.","DOI":"10.1101\/2021.11.24.21266779"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2021.03.100","article-title":"SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration","volume":"554","author":"Idrees","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Mysiris, D.S., Vavougios, G.D., Karamichali, E., Papoutsopoulou, S., Stavrou, V.T., Papayianni, E., Boutlas, S., Mavridis, T., Foka, P., and Zarogiannis, S.G. (2022). Post-COVID-19 Parkinsonism and Parkinson\u2019s Disease Pathogenesis: The Exosomal Cargo Hypothesis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179739"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2017.00138","article-title":"Age-Dependent Protein Aggregation Initiates Amyloid-beta Aggregation","volume":"9","author":"Groh","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0194599820934769","article-title":"Persistent Smell Loss Following Undetectable SARS-CoV-2","volume":"63","author":"Yan","year":"2020","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hed.26288","article-title":"Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients","volume":"42","author":"Farri","year":"2020","journal-title":"Head Neck"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","article-title":"Real-time tracking of self-reported symptoms to predict potential COVID-19","volume":"26","author":"Menni","year":"2020","journal-title":"Nat. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e20202135","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10571-020-00915-1","article-title":"Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus","volume":"42","author":"Xu","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e140766","DOI":"10.1172\/JCI140766","article-title":"Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium","volume":"131","author":"Schuler","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jnr.24752","article-title":"Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?","volume":"99","author":"Uversky","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"119201","DOI":"10.1016\/j.lfs.2021.119201","article-title":"COVID-19, cytokines, inflammation, and spices: How are they related?","volume":"284","author":"Kunnumakkara","year":"2021","journal-title":"Life Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s40478-022-01493-7","article-title":"Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases","volume":"10","author":"Agrawal","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Plini, E.R.G., O\u2019Hanlon, E., Boyle, R., Sibilia, F., Rikhye, G., Kenney, J., Whelan, R., Melnychuk, M.C., Robertson, I.H., and Dockree, P.M. (2021). Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer\u2019s Disease Neuroimaging Initiative. Cells, 10.","DOI":"10.20944\/preprints202104.0532.v1"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Bocci, M., Oudenaarden, C., Saenz-Sarda, X., Simren, J., Eden, A., Sjolund, J., Moller, C., Gisslen, M., Zetterberg, H., and Englund, E. (2021). Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients. Int. J. Mol. Sci., 22.","DOI":"10.1101\/2021.05.24.445532"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Serrano, G.E., Walker, J.E., Arce, R., Glass, M.J., Vargas, D., Sue, L.I., Intorcia, A.J., Nelson, C.M., Oliver, J., and Papa, J. (2021). Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv.","DOI":"10.1101\/2021.02.15.21251511"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s11606-020-06527-1","article-title":"Impact of Race and Socioeconomic Status on Outcomes in Patients Hospitalized with COVID-19","volume":"36","author":"Quan","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-3-642-17214-4_11","article-title":"Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes","volume":"Volume 203","author":"Schwanstecher","year":"2011","journal-title":"Diabetes-Perspectives in Drug Therapy"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/exnr.2000.7595","article-title":"Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia","volume":"168","author":"Friedman","year":"2001","journal-title":"Exp. Neurol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tem.2022.04.011","article-title":"Neurological aspects of SARS-CoV-2 infection: Lipoproteins and exosomes as Trojan horses","volume":"33","author":"Lam","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"785941","DOI":"10.3389\/fimmu.2021.785941","article-title":"Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response","volume":"12","author":"Pesce","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: Therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11481-017-9768-z","article-title":"Extracellular Vesicle Biology in Alzheimer\u2019s Disease and Related Tauopathy","volume":"13","author":"DeLeo","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.freeradbiomed.2017.08.028","article-title":"Exosomal biomarkers in Down syndrome and Alzheimer\u2019s disease","volume":"114","author":"Hamlett","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jalz.2016.08.012","article-title":"Neuronal exosomes reveal Alzheimer\u2019s disease biomarkers in Down syndrome","volume":"13","author":"Hamlett","year":"2016","journal-title":"Alzheimers Dement."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"716407","DOI":"10.3389\/fimmu.2021.716407","article-title":"Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments","volume":"12","author":"Gurunathan","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/14756366.2020.1754814","article-title":"Advances in the discovery of exosome inhibitors in cancer","volume":"35","author":"Zhang","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1096\/fj.201802319R","article-title":"Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury","volume":"33","author":"Goetzl","year":"2019","journal-title":"FASEB J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1096\/fj.201600756R","article-title":"Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer\u2019s disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Guix, F.X., Corbett, G.T., Cha, D.J., Mustapic, M., Liu, W., Mengel, D., Chen, Z., Aikawa, E., Young-Pearse, T., and Kapogiannis, D. (2018). Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030663"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/02699052.2018.1483530","article-title":"Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury","volume":"32","author":"Kenney","year":"2018","journal-title":"Brain Inj."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in Exosome Isolation Techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7326\/M20-4986","article-title":"COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults","volume":"174","author":"Clift","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"100019","DOI":"10.1016\/j.xcrm.2020.100019","article-title":"Down Syndrome and COVID-19: A Perfect Storm?","volume":"1","author":"Espinosa","year":"2020","journal-title":"Cell. Rep. Med."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Huls, A., Feany, P.T., Zisman, S.I., Costa, A.C.S., Dierssen, M., Balogh, R., Bargagna, S., Baumer, N.T., Brandao, A.C., and Carfi, A. (2022). COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated. Vaccines, 10.","DOI":"10.3390\/vaccines10040530"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13063-016-1370-9","article-title":"Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial","volume":"17","author":"Cooper","year":"2016","journal-title":"Trials"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4093\/dmj.2014.38.6.464","article-title":"A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome","volume":"38","author":"Parra","year":"2014","journal-title":"Diabetes Metab. J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbadis.2015.11.007","article-title":"Cerebrovascular contributions to aging and Alzheimer\u2019s disease in Down syndrome","volume":"1862","author":"Wilcock","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"621440","DOI":"10.3389\/fimmu.2021.621440","article-title":"Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome","volume":"12","author":"Illouz","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"160098","DOI":"10.1183\/16000617.0098-2016","article-title":"What people with Down Syndrome can teach us about cardiopulmonary disease","volume":"26","author":"Colvin","year":"2017","journal-title":"Eur. Respir. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.3389\/fimmu.2018.03058","article-title":"The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System","volume":"9","author":"Satge","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"102322","DOI":"10.1016\/j.isci.2021.102322","article-title":"Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19","volume":"24","author":"Andolfo","year":"2021","journal-title":"iScience"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"463909","DOI":"10.1155\/2012\/463909","article-title":"Age-related neurodegeneration and memory loss in down syndrome","volume":"2012","author":"Lockrow","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"ref_143","first-page":"11","article-title":"Down syndrome and microRNAs","volume":"8","author":"Bras","year":"2018","journal-title":"Biomed. Rep."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3389\/fimmu.2020.00625","article-title":"MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases","volume":"11","author":"Pasca","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Derkow, K., Rossling, R., Schipke, C., Kruger, C., Bauer, J., Fahling, M., Stroux, A., Schott, E., Ruprecht, K., and Peters, O. (2018). Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200602"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijid.2020.06.027","article-title":"Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak","volume":"97","author":"Penarrubia","year":"2020","journal-title":"Int. J. Infect. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3190\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:26:05Z","timestamp":1760124365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/9\/3190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":146,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["jcm12093190"],"URL":"https:\/\/doi.org\/10.3390\/jcm12093190","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}